Funding for this research was provided by:
National Institute for Health Research (RP-PG-1212-20018)
Received: 25 June 2018
Accepted: 31 January 2019
First Online: 11 February 2019
Ethics approval and consent to participate
: The study received Ethics approval from West Midlands – Black Country Research Ethics Committee (15/WM/0165). Participants provided written consent to take part in the study.
: MU was Chair of the NICE accreditation advisory committee until March 2017 for which he received a fee. He is chief investigator or co-investigator on multiple previous and current research grants from the UK National Institute for Health Research, Arthritis Research UK and is a co-investigator on grants funded by Arthritis Australia and Australian NHMRC. He has received travel expenses for speaking at conferences from the professional organisations hosting the conferences He is a director and shareholder of Clinvivo Ltd. that provides electronic data collection for health services research. Use of Clinvivo’s App for this study was specified in original application for funding. MU has had no subsequent involvement in the tendering and contracting by University of Warwick and no involvement in the service provision by Clinvivo Ltd. related to this study. He is part of an academic partnership with Serco Ltd. related to return to work initiatives. He is an editor of the NIHR journal series for which he receives a fee.MM has served on the advisory board for Allergan, Medtronic, Novartis and Eli Lilly and has received payment for the development of educational presentations from Medtronic, Allergan and electroCore.SP is a director of Health Psychology Services Ltd. which in part provides psychological treatments for those with chronic pain.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.